137 related articles for article (PubMed ID: 20030620)
21. Elimination of up to 80% of human pancreatic adenocarcinomas in athymic mice by cardiac hormones.
Vesely DL; Eichelbaum EJ; Sun Y; Alli AA; Vesely BA; Luther SL; Gower WR
In Vivo; 2007; 21(3):445-51. PubMed ID: 17591353
[TBL] [Abstract][Full Text] [Related]
22. Urodilatin and four cardiac hormones decrease human renal carcinoma cell numbers.
Vesely BA; Eichelbaum EJ; Alli AA; Sun Y; Gower WR; Vesely DL
Eur J Clin Invest; 2006 Nov; 36(11):810-9. PubMed ID: 17032349
[TBL] [Abstract][Full Text] [Related]
23. Potent selective inhibition of STAT 3 versus STAT 1 by cardiac hormones.
Lane ML; Frost CD; Nguyen JP; Skelton WP; Skelton M; Vesely DL
Mol Cell Biochem; 2012 Dec; 371(1-2):209-15. PubMed ID: 22965761
[TBL] [Abstract][Full Text] [Related]
24. Central role of β-catenin in anticancer effects of cardiac hormones.
Skelton WP; Skelton M; Vesely DL
Anticancer Res; 2013 Jun; 33(6):2409-14. PubMed ID: 23749889
[TBL] [Abstract][Full Text] [Related]
25. Four peptide hormones decrease the number of human breast adenocarcinoma cells.
Vesely BA; Song S; Sanchez-Ramos J; Fitz SR; Solivan SM; Gower WR; Vesely DL
Eur J Clin Invest; 2005 Jan; 35(1):60-9. PubMed ID: 15638821
[TBL] [Abstract][Full Text] [Related]
26. Four cardiac hormones eliminate up to 82% of human medullary thyroid carcinoma cells within 24 hours.
Eichelbaum EJ; Vesely BA; Alli AA; Sun Y; Gower WR; Vesely DL
Endocrine; 2006 Dec; 30(3):325-32. PubMed ID: 17526945
[TBL] [Abstract][Full Text] [Related]
27. Novel dual inhibitors of vascular endothelial growth factor and VEGFR2 receptor.
Nguyen JP; Frost CD; Lane ML; Skelton WP; Skelton M; Vesely DL
Eur J Clin Invest; 2012 Oct; 42(10):1061-7. PubMed ID: 22703300
[TBL] [Abstract][Full Text] [Related]
28. Atrial natriuretic peptide and long acting natriuretic peptide inhibit ERK 1/2 in prostate cancer cells.
Sun Y; Eichelbaum EJ; Wang H; Vesely DL
Anticancer Res; 2006; 26(6B):4143-8. PubMed ID: 17201125
[TBL] [Abstract][Full Text] [Related]
29. Long-acting natriuretic peptide, vessel dilator, and kaliuretic peptide enhance the urinary excretion rate of beta2-microglobulin.
Vesely DL; Perez-Lamboy GI; Schocken DD
Metabolism; 2000 Dec; 49(12):1592-7. PubMed ID: 11145122
[TBL] [Abstract][Full Text] [Related]
30. Cardiac hormones inhibit proliferation of pancreatic cancer but not normal cells.
Skelton WP; Pi G; Lenz A; Sun Y; Vesely DL
Eur J Clin Invest; 2010 Aug; 40(8):706-12. PubMed ID: 20546014
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of AKT in human pancreatic, renal and colorectal cancer cells by four cardiac hormones.
Skelton WP; Skelton M; Vesely DL
Anticancer Res; 2013 Mar; 33(3):785-90. PubMed ID: 23482745
[TBL] [Abstract][Full Text] [Related]
32. Cardiac hormones are c-Jun-N-terminal kinase 2-inhibiting peptides.
Lane ML; Santana O; Frost CD; Nguyen J; Guerrero J; Skelton WP; Skelton M; Vesely DL
Anticancer Res; 2012 Mar; 32(3):721-5. PubMed ID: 22399583
[TBL] [Abstract][Full Text] [Related]
33. C-type natriuretic peptide and brain natriuretic peptide inhibit adenylyl cyclase activity: interaction with ANF-R2/ANP-C receptors.
Savoie P; de Champlain J; Anand-Srivastava MB
FEBS Lett; 1995 Aug; 370(1-2):6-10. PubMed ID: 7649305
[TBL] [Abstract][Full Text] [Related]
34. The natriuretic peptides BNP and CNP increase heart rate and electrical conduction by stimulating ionic currents in the sinoatrial node and atrial myocardium following activation of guanylyl cyclase-linked natriuretic peptide receptors.
Springer J; Azer J; Hua R; Robbins C; Adamczyk A; McBoyle S; Bissell MB; Rose RA
J Mol Cell Cardiol; 2012 May; 52(5):1122-34. PubMed ID: 22326431
[TBL] [Abstract][Full Text] [Related]
35. Four cardiac hormones eliminate 4-fold more human glioblastoma cells than the green mamba snake peptide.
Vesely BA; Eichelbaum EJ; Alli AA; Sun Y; Gower WR; Vesely DL
Cancer Lett; 2007 Aug; 254(1):94-101. PubMed ID: 17399891
[TBL] [Abstract][Full Text] [Related]
36. Vessel dilator and kaliuretic peptide inhibit MEK 1/2 activation in human prostate cancer cells.
Sun Y; Eichelbaum EJ; Wang H; Vesely DL
Anticancer Res; 2007; 27(3B):1387-92. PubMed ID: 17595752
[TBL] [Abstract][Full Text] [Related]
37. Four peptides decrease the number of human pancreatic adenocarcinoma cells.
Vesely BA; McAfee Q; Gower WR; Vesely DL
Eur J Clin Invest; 2003 Nov; 33(11):998-1005. PubMed ID: 14636304
[TBL] [Abstract][Full Text] [Related]
38. Atrial natriuretic peptide prohormone gene expression: hormones and diseases that upregulate its expression.
Vesely DL
IUBMB Life; 2002 Mar; 53(3):153-9. PubMed ID: 12102171
[TBL] [Abstract][Full Text] [Related]
39. Atrial natriuretic peptide and long acting natriuretic peptide inhibit MEK 1/2 activation in human prostate cancer cells.
Sun Y; Eichelbaum EJ; Wang H; Vesely DL
Anticancer Res; 2007; 27(6B):3813-8. PubMed ID: 18225537
[TBL] [Abstract][Full Text] [Related]
40. Vessel dilator and kaliuretic peptide inhibit ERK 1/2 activation in human prostate cancer cells.
Sun Y; Eichelbaum EJ; Wang H; Vesely DL
Anticancer Res; 2006; 26(5A):3217-22. PubMed ID: 17094432
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
